5,775 Shares in DocuSign, Inc. (NASDAQ:DOCU) Bought by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC purchased a new stake in DocuSign, Inc. (NASDAQ:DOCU) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,775 shares of the company’s stock, valued at approximately $519,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCU. Oak Thistle LLC acquired a new stake in DocuSign during the fourth quarter worth about $954,000. Miracle Mile Advisors LLC purchased a new stake in DocuSign in the 4th quarter worth approximately $257,000. Friedenthal Financial acquired a new stake in shares of DocuSign during the 4th quarter worth approximately $54,000. Nordea Investment Management AB increased its holdings in shares of DocuSign by 35.4% during the 4th quarter. Nordea Investment Management AB now owns 819,221 shares of the company’s stock valued at $74,131,000 after purchasing an additional 214,298 shares in the last quarter. Finally, Everence Capital Management Inc. acquired a new position in shares of DocuSign in the 4th quarter valued at $720,000. 77.64% of the stock is owned by institutional investors and hedge funds.

DocuSign Stock Down 0.2 %

DocuSign stock opened at $91.16 on Friday. The company has a fifty day simple moving average of $88.26 and a 200-day simple moving average of $69.77. The firm has a market capitalization of $18.42 billion, a price-to-earnings ratio of 18.80, a PEG ratio of 8.17 and a beta of 0.88. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.

Insider Activity at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,764 shares of the business’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the transaction, the chief executive officer now owns 107,825 shares of the company’s stock, valued at approximately $7,542,358.75. The trade was a 6.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the sale, the director now owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 693,537 shares of company stock valued at $66,575,817. Corporate insiders own 1.66% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. UBS Group raised their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Robert W. Baird raised their target price on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Morgan Stanley lifted their price target on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. increased their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Tuesday, December 3rd. Finally, Piper Sandler boosted their price objective on DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, DocuSign presently has an average rating of “Hold” and an average price target of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.